CORRESP Filing
Immix Biopharma, Inc.
Date: Nov. 26, 2025 · CIK: 0001873835 · Accession: 0001493152-25-025192
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290725
Letter
Re: Immix Biopharma, Inc.
November 26, 2025
Division of Corporation Finance VIA EDGAR
U.S. Securities and Exchange Commission
Washington D.C. 20549
Form S-3 Registration Statement
File No. 333-290725
Acceleration Request
Request Date : December 1, 2025
Request Time : 4:30 p.m. Eastern Time (or as soon thereafter as practicable)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Immix Biopharma, Inc. (the " Registrant ") hereby requests that the United States Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-captioned Registration Statement (the " Registration Statement ") to become effective at 4:30 p.m. Eastern Standard Time, Monday, December 1, 2025, or as soon thereafter as practicable.
Please contact Mr. David M. Loev of The Loev Law Firm, PC at (832) 930-6432, with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Very
truly yours,
/s/
Gabriel Morris
Show Raw Text
CORRESP 1 filename1.htm November 26, 2025 Division of Corporation Finance VIA EDGAR U.S. Securities and Exchange Commission Washington D.C. 20549 Re: Immix Biopharma, Inc. Form S-3 Registration Statement File No. 333-290725 Acceleration Request Request Date : December 1, 2025 Request Time : 4:30 p.m. Eastern Time (or as soon thereafter as practicable) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Immix Biopharma, Inc. (the " Registrant ") hereby requests that the United States Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-captioned Registration Statement (the " Registration Statement ") to become effective at 4:30 p.m. Eastern Standard Time, Monday, December 1, 2025, or as soon thereafter as practicable. Please contact Mr. David M. Loev of The Loev Law Firm, PC at (832) 930-6432, with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Very truly yours, /s/ Gabriel Morris Gabriel Morris Chief Financial Officer